Clinical Trial Update: TIV and High Dose TIV in Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing standard trivalent influenza vaccine (TIV) and high-dose TIV in subjects with rheumatoid arthritis to evaluate safety and immunogenicity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• High-dose trivalent influenza vaccine (High-dose trivalent inactivated influenza vaccine)
• Trivalent influenza vaccine (Influenza vaccine, trivalent)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza | Phase 2 | Status: COMPLETED | Results posted: 2014-05-16